Todos Medical
Life-Saving Diagnostic Solutions For A Healthier Tomorrow.
| USD | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | - | 135 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | (466 %) | (59 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | - | (572 %) | (354 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | - | - | 189 % | 7 % |
Source: Company filings or news article
Related Content
Todos Medical is a biotechnology company specializing in the development and commercialization of diagnostic solutions, particularly in the field of COVID-19 testing. The company serves healthcare providers, laboratories, and public health organizations, operating primarily in the medical diagnostics market. Todos Medical's business model revolves around the sale of diagnostic reagents and automated extraction systems, such as the ANDiS 350, which streamline and enhance the efficiency of COVID-19 testing processes. Revenue is generated through the direct sale of these products and through strategic partnerships and collaborations. The company has expanded its management team and advisory board to support its growth and innovation initiatives.
Keywords: biotechnology, diagnostics, COVID-19, testing, reagents, automation, healthcare, laboratories, efficiency, innovation.
Tech stack
Investments by Todos Medical
Edit